Skip to main content

01-10-2020 | ESMO 2020 | Conference coverage | Video

IMpassion130 and IMpassion131: The difference a taxane makes?

Leisha Emens summarizes their IMpassion130 trial of atezolizumab and nab-paclitaxel in patients with advanced triple-negative breast cancer, and comments on the differences with the IMpassion131 study that instead used paclitaxel (2:19).

Read transcript